BIOEXTRAX AB (85X0) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BIOEXTRAX AB (85X0) has a cash flow conversion efficiency ratio of 0.455x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€7.68 Million ≈ $8.97 Million USD) by net assets (€16.89 Million ≈ $19.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View 85X0 live share price for real-time trading data and today's change.
BIOEXTRAX AB - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how BIOEXTRAX AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see BIOEXTRAX AB market capitalisation for the company's overall valuation and market capitalisation.
BIOEXTRAX AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BIOEXTRAX AB ranked by their cash flow conversion efficiency. Also see balance sheet size of BIOEXTRAX AB for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Spineguard
PA:ALSGD
|
-0.172x |
|
mVISE AG
XETRA:C1V
|
0.092x |
|
Centrex Ltd
AU:CXM
|
-0.301x |
|
Txcom SA
PA:ALTXC
|
-0.023x |
|
Yelooo Integra Datanet Tbk PT
JK:YELO
|
-0.001x |
|
Tian An Australia Ltd
AU:TIA
|
0.083x |
|
Landmark Property Development Company Limited
NSE:LPDC
|
0.060x |
|
Vessel Co. Ltd
KQ:177350
|
0.035x |
Annual Cash Flow Conversion Efficiency for BIOEXTRAX AB (2021–2025)
The table below shows the annual cash flow conversion efficiency of BIOEXTRAX AB from 2021 to 2025. Review BIOEXTRAX AB (85X0) financial flexibility to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €21.21 Million ≈ $24.80 Million |
€-26.05 Million ≈ $-30.45 Million |
-1.228x | -70.38% |
| 2024-12-31 | €26.06 Million ≈ $30.47 Million |
€-18.78 Million ≈ $-21.95 Million |
-0.721x | +36.52% |
| 2023-12-31 | €20.54 Million ≈ $24.01 Million |
€-23.31 Million ≈ $-27.25 Million |
-1.135x | -104.83% |
| 2022-12-31 | €31.77 Million ≈ $37.14 Million |
€-17.60 Million ≈ $-20.58 Million |
-0.554x | +50.98% |
| 2021-12-31 | €7.50 Million ≈ $8.77 Million |
€-8.48 Million ≈ $-9.91 Million |
-1.130x | -- |
About BIOEXTRAX AB
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; … Read more